Round marks major expansion of FIZE Medical's strategic relationship with Asahi Kasei Medical, including distribution in Japan and Europe, and accelerates development of its next-generation predictive, AI-guided fluid management platform
JERICHO, N.Y., Sept. 17, 2026 /PRNewswire/ -- FIZE Medical, a leader in smart fluid management solutions for critically ill patients, today announced the first close of its Series B financing round, co-led by Asahi Kasei Medical and Rapha Capital Management, making significant headway towards the company's $20 million financing target.
The financing comes at a pivotal point in FIZE Medical's growth, as the company expands its commercial footprint and advances its next-generation FIZE Optima platform toward predictive, AI-guided clinical decision support.